{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:55:58Z","timestamp":1778864158917,"version":"3.51.4"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s11033-023-08852-0","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T12:01:52Z","timestamp":1696420912000},"page":"9601-9623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Understanding crosstalk of organ tropism, tumor microenvironment and noncoding RNAs in breast cancer metastasis"],"prefix":"10.1007","volume":"50","author":[{"given":"Sohini","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0986-2796","authenticated-orcid":false,"given":"Satarupa","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"8852_CR1","doi-asserted-by":"publisher","first-page":"602416","DOI":"10.3389\/fonc.2020.602416","volume":"10","author":"L Wang","year":"2021","unstructured":"Wang L, Zhang S, Wang X (2021) The metabolic mechanisms of breast cancer metastasis. Front Oncol 10:602416","journal-title":"Front Oncol"},{"key":"8852_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/BCR2944","author":"H Sihto","year":"2011","unstructured":"Sihto H, Lundin J, Lundin M et al (2011) Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: A nationwide cohort study. Breast Cancer Res. https:\/\/doi.org\/10.1186\/BCR2944","journal-title":"Breast Cancer Res"},{"issue":"150","key":"8852_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/S10549-015-3341-3","volume":"1503","author":"K Kast","year":"2015","unstructured":"Kast K, Link T, Friedrich K et al (2015) (2015) Impact of breast cancer subtypes and patterns of metastasis on outcome. Breast Cancer Res Treat 1503(150):621\u2013629. https:\/\/doi.org\/10.1007\/S10549-015-3341-3","journal-title":"Breast Cancer Res Treat"},{"key":"8852_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/ANNONC\/MDR154","volume":"23","author":"R Yerushalmi","year":"2012","unstructured":"Yerushalmi R, Tyldesley S, Kennecke H et al (2012) Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. Ann Oncol 23:338\u2013345. https:\/\/doi.org\/10.1093\/ANNONC\/MDR154","journal-title":"Ann Oncol"},{"key":"8852_CR5","unstructured":"CTCs as Predictors of Metastatic Spread in Breast Cancer. https:\/\/www.medscape.com\/viewarticle\/837900. Accessed 29 Mar 2022"},{"key":"8852_CR6","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1158\/1055-9965.EPI-08-1173","volume":"18","author":"OB Goodman","year":"2009","unstructured":"Goodman OB, Fink LM, Symanowski JT et al (2009) Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors. Cancer Epidemiol Biomarkers Prev 18:1904\u20131913. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-1173","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"8852_CR7","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1158\/0008-5472.CAN-07-5644","volume":"68","author":"M Smid","year":"2008","unstructured":"Smid M, Wang Y, Zhang Y et al (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68:3108\u20133114. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5644","journal-title":"Cancer Res"},{"key":"8852_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1677\/ERC-06-0001","volume":"13","author":"M Lacroix","year":"2006","unstructured":"Lacroix M (2006) Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer 13:1033\u20131067. https:\/\/doi.org\/10.1677\/ERC-06-0001","journal-title":"Endocr Relat Cancer"},{"issue":"137","key":"8852_CR9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/S00432-011-0988-Y","volume":"1378","author":"YF Sun","year":"2011","unstructured":"Sun YF, Yang XR, Zhou J et al (2011) (2011) Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance. J Cancer Res Clin Oncol 1378(137):1151\u20131173. https:\/\/doi.org\/10.1007\/S00432-011-0988-Y","journal-title":"J Cancer Res Clin Oncol"},{"key":"8852_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/CANCERS10100380","author":"NBA Razak","year":"2018","unstructured":"Razak NBA, Jones G, Bhandari M et al (2018) Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers (Basel). https:\/\/doi.org\/10.3390\/CANCERS10100380","journal-title":"Cancers (Basel)"},{"key":"8852_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/oxfordjournals.jncimonographs.a003463","volume":"2001","author":"B Fisher","year":"2001","unstructured":"Fisher B, Jeong JH, Dignam J et al (2001) Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer. J Natl Cancer Inst Monogr 2001:62\u201366","journal-title":"J Natl Cancer Inst Monogr"},{"key":"8852_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1302\/2058-5241.1.000008","volume":"1","author":"JJ Willeumier","year":"2016","unstructured":"Willeumier JJ, Linden YM, va. der, Sande MAJ va. de, Dijkstra PDS, (2016) Treatment of pathological fractures of the long bones. EFORT Open Rev 1:136. https:\/\/doi.org\/10.1302\/2058-5241.1.000008","journal-title":"EFORT Open Rev"},{"key":"8852_CR13","unstructured":"High Calcium Levels or Hypercalcemia | Cancer.Net. https:\/\/www.cancer.net\/coping-with-cancer\/physical-emotional-and-social-effects-cancer\/managing-physical-side-effects\/high-calcium-levels-or-hypercalcemia. Accessed 30 Mar 2022"},{"key":"8852_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2018.1456599","author":"L Jin","year":"2018","unstructured":"Jin L, Han B, Siegel E et al (2018) Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biol Ther. https:\/\/doi.org\/10.1080\/15384047.2018.1456599","journal-title":"Cancer Biol Ther"},{"key":"8852_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12967-015-0425-0","volume":"13","author":"R Ma","year":"2015","unstructured":"Ma R, Feng Y, Lin S et al (2015) Mechanisms involved in breast cancer liver metastasis. J Transl Med 13:64","journal-title":"J Transl Med"},{"key":"8852_CR16","unstructured":"Brain and Spinal Cord Tumors: Hope Through Research | National Institute of Neurological Disorders and Stroke. https:\/\/www.ninds.nih.gov\/Disorders\/Patient-Caregiver-Education\/Hope-Through-Research\/Brain-and-Spinal-Tumors-Hope-Through. Accessed 30 Mar 2022"},{"key":"8852_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/014107688708000811","author":"PJ Woll","year":"1987","unstructured":"Woll PJ, Knight RK, Rubens RD (1987) Pericardial effusion complicating breast cancer. J R Soc Med. https:\/\/doi.org\/10.1177\/014107688708000811","journal-title":"J R Soc Med"},{"key":"8852_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-04997-6","author":"JY Kim","year":"2020","unstructured":"Kim JY, Jeon JY, Choi YJ et al (2020) Characteristics of metastatic brachial plexopathy in patients with breast cancer. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-019-04997-6","journal-title":"Support Care Cancer"},{"key":"8852_CR19","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-10-1040","volume":"70","author":"JE Talmadge","year":"2010","unstructured":"Talmadge JE, Fidler IJ (2010) AACR centennial series: The biology of cancer metastasis: Historical perspective. Cancer Res 70:5649\u20135669","journal-title":"Cancer Res"},{"key":"8852_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S10585-021-10090-2","volume":"1","author":"SD Nathanson","year":"2021","unstructured":"Nathanson SD, Detmar M, Padera TP et al (2021) Mechanisms of breast cancer metastasis. Clin Exp Metastasis 1:1\u201321. https:\/\/doi.org\/10.1007\/S10585-021-10090-2","journal-title":"Clin Exp Metastasis"},{"key":"8852_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/283139A0","volume":"283","author":"G Poste","year":"1980","unstructured":"Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283:139\u2013146. https:\/\/doi.org\/10.1038\/283139A0","journal-title":"Nature"},{"key":"8852_CR22","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1007\/S00018-007-7388-0","volume":"64","author":"EA McSherry","year":"2007","unstructured":"McSherry EA, Donatello S, Hopkins AM, McDonnell S (2007) Molecular basis of invasion in breast cancer. Cell Mol Life Sci 64:3201\u20133218. https:\/\/doi.org\/10.1007\/S00018-007-7388-0","journal-title":"Cell Mol Life Sci"},{"key":"8852_CR23","first-page":"11","volume":"6","author":"CD Bell","year":"1986","unstructured":"Bell CD, Waizbard E (1986) Variability of cell size in primary and metastatic human breast carcinoma. Invasion Metastasis 6:11\u201320","journal-title":"Invasion Metastasis"},{"key":"8852_CR24","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/J.CCELL.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu Y, Cao X (2016) Characteristics and significance of the pre-metastatic Niche. Cancer Cell 30:668\u2013681. https:\/\/doi.org\/10.1016\/J.CCELL.2016.09.011","journal-title":"Cancer Cell"},{"key":"8852_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/S10555-006-9036-9","volume":"25","author":"RN Kaplan","year":"2006","unstructured":"Kaplan RN, Psaila B, Lyden D (2006) Bone marrow cells in the \u201cpre-metastatic niche\u201d: within bone and beyond. Cancer Metastasis Rev 25:521\u2013529. https:\/\/doi.org\/10.1007\/S10555-006-9036-9","journal-title":"Cancer Metastasis Rev"},{"key":"8852_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/S13046-018-0761-Z","author":"S Wu","year":"2018","unstructured":"Wu S, Zheng Q, Xing X et al (2018) Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation. J Exp Clin Cancer Res. https:\/\/doi.org\/10.1186\/S13046-018-0761-Z","journal-title":"J Exp Clin Cancer Res"},{"key":"8852_CR27","doi-asserted-by":"publisher","first-page":"16369","DOI":"10.1073\/pnas.1113483108","volume":"108","author":"CCL Wong","year":"2011","unstructured":"Wong CCL, Gilkes DM, Zhang H et al (2011) Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc Natl Acad Sci U S A 108:16369\u201316374","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8852_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/S10555-006-9019-X","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Loberg R, Taichman RS (2006) The pivotal role of CXCL12 (SDF-1)\/CXCR4 axis in bone metastasis. Cancer Metastasis Rev 25:573\u2013587. https:\/\/doi.org\/10.1007\/S10555-006-9019-X","journal-title":"Cancer Metastasis Rev"},{"key":"8852_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/cells8020089","volume":"8","author":"N Gandhi","year":"2019","unstructured":"Gandhi N, Das GM (2019) Metabolic reprogramming in breast cancer and its therapeutic implications. Cells 8:89","journal-title":"Cells"},{"key":"8852_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2015.08.005","author":"RV Sim\u00f5es","year":"2015","unstructured":"Sim\u00f5es RV, Serganova IS, Kruchevsky N et al (2015) Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment. Neoplasia (United States). https:\/\/doi.org\/10.1016\/j.neo.2015.08.005","journal-title":"Neoplasia (United States)"},{"key":"8852_CR31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3137","author":"EI Chen","year":"2007","unstructured":"Chen EI, Hewel J, Krueger JS et al (2007) Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res: https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3137","journal-title":"Cancer Res:"},{"key":"8852_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.08.007","author":"F Dupuy","year":"2015","unstructured":"Dupuy F, Tabari\u00e8s S, Andrzejewski S et al (2015) PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer. Cell Metab: https:\/\/doi.org\/10.1016\/j.cmet.2015.08.007","journal-title":"Cell Metab:"},{"key":"8852_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120958","author":"D Verduzco","year":"2015","unstructured":"Verduzco D, Lloyd M, Xu L et al (2015) Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistance. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0120958","journal-title":"PLoS ONE"},{"key":"8852_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12004","author":"M Mimeault","year":"2013","unstructured":"Mimeault M, Batra SK (2013) Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J Cell Mol Med. https:\/\/doi.org\/10.1111\/jcmm.12004","journal-title":"J Cell Mol Med"},{"key":"8852_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1477-7827-2-2","volume":"2","author":"DA Stewart","year":"2004","unstructured":"Stewart DA, Cooper CR, Sikes RA (2004) Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol 2:2","journal-title":"Reprod Biol Endocrinol"},{"key":"8852_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020758","author":"C Fazakas","year":"2011","unstructured":"Fazakas C, Wilhelm I, Nagyoszi P et al (2011) Transmigration of melanoma cells through the blood-brain barrier: Role of endothelial tight junctions and melanoma-released serine proteases. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0020758","journal-title":"PLoS ONE"},{"key":"8852_CR37","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/ijms14011383","volume":"14","author":"I Wilhelm","year":"2013","unstructured":"Wilhelm I, Moln\u00e1r J, Fazakas C et al (2013) Role of the blood-brain barrier in the formation of brain metastases. Int J Mol Sci 14:1383","journal-title":"Int J Mol Sci"},{"key":"8852_CR38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10585-007-9098-2","volume":"25","author":"FL Miles","year":"2008","unstructured":"Miles FL, Pruitt FL, Van Golen KL, Cooper CR (2008) Stepping out of the flow: Capillary extravasation in cancer metastasis. Clin Exp Metastasis 25:305","journal-title":"Clin Exp Metastasis"},{"key":"8852_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2072","author":"Y Kienast","year":"2010","unstructured":"Kienast Y, Von Baumgarten L, Fuhrmann M et al (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat Med. https:\/\/doi.org\/10.1038\/nm.2072","journal-title":"Nat Med"},{"key":"8852_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1610","author":"C Sheridan","year":"2006","unstructured":"Sheridan C, Kishimoto H, Fuchs RK et al (2006) CD44+\/CD24-Breast cancer cells exhibit enhanced invase properties: An early step necessary for metastasis. Breast Cancer Res. https:\/\/doi.org\/10.1186\/bcr1610","journal-title":"Breast Cancer Res"},{"key":"8852_CR41","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/28961","volume":"394","author":"DR Edwards","year":"1998","unstructured":"Edwards DR, Murphy G (1998) Cancer proteases - invasion and more. Nature 394:527","journal-title":"Nature"},{"key":"8852_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.01.040","author":"M Valiente","year":"2014","unstructured":"Valiente M, Obenauf AC, Jin X et al (2014) Serpins promote cancer cell survival and vascular Co-option in brain metastasis. Cell. https:\/\/doi.org\/10.1016\/j.cell.2014.01.040","journal-title":"Cell"},{"key":"8852_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344214","author":"K Sathiyanadan","year":"2014","unstructured":"Sathiyanadan K, Coisne C, Enzmann G et al (2014) PSGL-1 and E\/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE. Eur J Immunol. https:\/\/doi.org\/10.1002\/eji.201344214","journal-title":"Eur J Immunol"},{"key":"8852_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005857","author":"WS Carbonell","year":"2009","unstructured":"Carbonell WS, Ansorga O, Sibson N, Muschel R (2009) The vascular basement membrane as \u201csoil\u201d in brain metastasis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0005857","journal-title":"PLoS ONE"},{"key":"8852_CR45","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1517\/14728222.11.11.1473","volume":"11","author":"SR Barthel","year":"2007","unstructured":"Barthel SR, Gavino JD, Descheny L, Dimitroff CJ (2007) Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 11:1473","journal-title":"Expert Opin Ther Targets"},{"key":"8852_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12038-008-0060-5","volume":"33","author":"P Seth","year":"2008","unstructured":"Seth P, Koul N (2008) Astrocyte, the star avatar: Redefined. J Biosci 33:405","journal-title":"J Biosci"},{"key":"8852_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-010-9354-8","author":"T Seike","year":"2011","unstructured":"Seike T, Fujita K, Yamakawa Y et al (2011) Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis. Clin Exp Metastasis. https:\/\/doi.org\/10.1007\/s10585-010-9354-8","journal-title":"Clin Exp Metastasis"},{"key":"8852_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/nature18268","author":"Q Chen","year":"2016","unstructured":"Chen Q, Boire A, Jin X et al (2016) Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature. https:\/\/doi.org\/10.1038\/nature18268","journal-title":"Nature"},{"key":"8852_CR49","doi-asserted-by":"publisher","DOI":"10.1593\/neo.11112","author":"SJ Kim","year":"2011","unstructured":"Kim SJ, Kim JS, Park ES et al (2011) Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia. https:\/\/doi.org\/10.1593\/neo.11112","journal-title":"Neoplasia"},{"key":"8852_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201201623","author":"F Xing","year":"2013","unstructured":"Xing F, Kobayashi A, Okuda H et al (2013) Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO Mol Med. https:\/\/doi.org\/10.1002\/emmm.201201623","journal-title":"EMBO Mol Med"},{"key":"8852_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","volume":"10","author":"W Kozlow","year":"2005","unstructured":"Kozlow W, Guise TA (2005) Breast cancer metastasis to bone: Mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 10:169","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"8852_CR52","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M","volume":"80","author":"TA Guise","year":"1997","unstructured":"Guise TA (1997) Parathyroid hormone-related protein and bone metastases. Cancer 80:1572","journal-title":"Cancer"},{"key":"8852_CR53","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026526703898","author":"AC Karaplis","year":"2000","unstructured":"Karaplis AC, Goltzman D (2000) PTH and PTHrP effects on the skeleton. Rev Endocr Metab Disord. https:\/\/doi.org\/10.1023\/A:1026526703898","journal-title":"Rev Endocr Metab Disord"},{"key":"8852_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/0955-2235(92)90019-E","author":"I Kawashima","year":"1992","unstructured":"Kawashima I, Takiguchi Y (1992) Interleukin-11: A novel stroma-derived cytokine. Prog Growth Factor Res. https:\/\/doi.org\/10.1016\/0955-2235(92)90019-E","journal-title":"Prog Growth Factor Res"},{"key":"8852_CR55","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3549","author":"Z Fasoulakis","year":"2018","unstructured":"Fasoulakis Z, Kolios G, Papamanolis V, Kontomanolis EN (2018) Interleukins associated with breast cancer. Cureus. https:\/\/doi.org\/10.7759\/cureus.3549","journal-title":"Cureus"},{"key":"8852_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00132-6","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. https:\/\/doi.org\/10.1016\/S1535-6108(03)00132-6","journal-title":"Cancer Cell"},{"key":"8852_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2007.09.021","author":"M Kinder","year":"2008","unstructured":"Kinder M, Chislock E, Bussard KM et al (2008) Metastatic breast cancer induces an osteoblast inflammatory response. Exp Cell Res. https:\/\/doi.org\/10.1016\/j.yexcr.2007.09.021","journal-title":"Exp Cell Res"},{"issue":"10","key":"8852_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1594-1","volume":"105","author":"M Liang","year":"2019","unstructured":"Liang M, Ma Q, Ding N et al (2019) (2019) IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis. Cell Death Dis 105(10):1\u201312. https:\/\/doi.org\/10.1038\/s41419-019-1594-1","journal-title":"Cell Death Dis"},{"key":"8852_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES9060659","author":"P Maroni","year":"2021","unstructured":"Maroni P, Bendinelli P, Ferraretto A, Lombardi G (2021) Interleukin 11 (IL-11): Role(s) in breast cancer bone metastases. Biomed. https:\/\/doi.org\/10.3390\/BIOMEDICINES9060659","journal-title":"Biomed"},{"key":"8852_CR60","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","volume":"6","author":"LA Kingsley","year":"2007","unstructured":"Kingsley LA, Fournier PGJ, Chirgwin JM, Guise TA (2007) Molecular biology of bone metastasis. Mol Cancer Ther 6:2609","journal-title":"Mol Cancer Ther"},{"key":"8852_CR61","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","volume":"142","author":"S Khosla","year":"2001","unstructured":"Khosla S (2001) Minireview: The OPG\/RANKL\/RANK system. Endocrinology 142:5050","journal-title":"Endocrinology"},{"key":"8852_CR62","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ctrv.2010.04.003","volume":"36","author":"RE Coleman","year":"2010","unstructured":"Coleman RE, Lipton A, Roodman GD et al (2010) Metastasis and bone loss: Advancing treatment and prevention. Cancer Treat Rev 36:615","journal-title":"Cancer Treat Rev"},{"key":"8852_CR63","first-page":"489","volume":"144","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP, Bouillon R, Clemens T et al (2018) Primer on the metabolic bone diseases and disorders of mineral metabolism. Indian J Med Res 144:489","journal-title":"Indian J Med Res"},{"key":"8852_CR64","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1012539107","author":"SL Stott","year":"2010","unstructured":"Stott SL, Hsu CH, Tsukrov DI et al (2010) Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.1012539107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8852_CR65","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/bies.10156","volume":"24","author":"IC MacDonald","year":"2002","unstructured":"MacDonald IC, Groom AC, Chambers AF (2002) Cancer spread and micrometastasis development: Quantitative approaches for in vivo models. BioEssays 24:885","journal-title":"BioEssays"},{"key":"8852_CR66","first-page":"2520","volume":"55","author":"S Koop","year":"1995","unstructured":"Koop S, MacDonald IC, Luzzi K et al (1995) Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. Cancer Res 55:2520","journal-title":"Cancer Res"},{"key":"8852_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.653521","author":"Y Qi","year":"2021","unstructured":"Qi Y, Zhang L, Wang Z et al (2021) Efficacy and safety of anti-PD-1\/ PD-L1 monotherapy for metastatic breast cancer: clinical evidence. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.653521","journal-title":"Front Pharmacol"},{"key":"8852_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0083-6","author":"W Yan","year":"2018","unstructured":"Yan W, Wu X, Zhou W et al (2018) Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol: https:\/\/doi.org\/10.1038\/s41556-018-0083-6","journal-title":"Nat Cell Biol:"},{"key":"8852_CR69","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.tme21-ia025","author":"SE Wang","year":"2021","unstructured":"Wang SE (2021) Abstract IA025: Local and systemic effects of cancer-cell-secreted extracellular miRNA. Cancer Res. https:\/\/doi.org\/10.1158\/1538-7445.tme21-ia025","journal-title":"Cancer Res"},{"key":"8852_CR70","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","volume":"25","author":"W Zhou","year":"2014","unstructured":"Zhou W, Fong MY, Min Y et al (2014) Cancer-Secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25:501\u2013515. https:\/\/doi.org\/10.1016\/j.ccr.2014.03.007","journal-title":"Cancer Cell"},{"key":"8852_CR71","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41422-018-0060-4","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Li CW, Chan LC et al (2018) Exosomal PD-L1 harbors active defense function to suppress t cell killing of breast cancer cells and promote tumor growth. Cell Res 28:862","journal-title":"Cell Res"},{"key":"8852_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3094","author":"MY Fong","year":"2015","unstructured":"Fong MY, Zhou W, Liu L et al (2015) Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol. https:\/\/doi.org\/10.1038\/ncb3094","journal-title":"Nat Cell Biol"},{"key":"8852_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/nature15756","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen TL et al (2015) Tumour exosome integrins determine organotropic metastasis. Nature. https:\/\/doi.org\/10.1038\/nature15756","journal-title":"Nature"},{"key":"8852_CR74","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nrc3747","volume":"14","author":"I Lokody","year":"2014","unstructured":"Lokody I (2014) Genetics: Exosomally derived miR-105 destroys tight junctions. Nat Rev Cancer 14:386","journal-title":"Nat Rev Cancer"},{"key":"8852_CR75","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.18632\/oncotarget.2427","volume":"5","author":"YN Joo","year":"2014","unstructured":"Joo YN, Jin H, Eun SY et al (2014) P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment. Oncotarget 5:9322","journal-title":"Oncotarget"},{"key":"8852_CR76","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cell.2008.01.046","volume":"133","author":"D Padua","year":"2008","unstructured":"Padua D, Zhang XH, Wang Q et al (2008) SUPP_TGF \u03b2 primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133:66","journal-title":"Cell"},{"key":"8852_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.08.025","author":"Q Chen","year":"2011","unstructured":"Chen Q, Zhang XHF, Massagu\u00e9 J (2011) Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccr.2011.08.025","journal-title":"Cancer Cell"},{"key":"8852_CR78","doi-asserted-by":"publisher","DOI":"10.7150\/thno.17138","author":"M Eisenblaetter","year":"2017","unstructured":"Eisenblaetter M, Flores-Borja F, Lee JJ et al (2017) Visualization of tumor-immune interaction\u2014Target-specific imaging of S100A8\/A9 reveals pre-metastatic niche establishment. Theranostics. https:\/\/doi.org\/10.7150\/thno.17138","journal-title":"Theranostics"},{"key":"8852_CR79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2010.02548.x","author":"B Furusato","year":"2010","unstructured":"Furusato B, Mohamed A, Uhl\u00e9n M, Rhim JS (2010) CXCR4 and cancer. Pathol Int. https:\/\/doi.org\/10.1111\/j.1440-1827.2010.02548.x","journal-title":"Pathol Int"},{"key":"8852_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/35065016","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature. https:\/\/doi.org\/10.1038\/35065016","journal-title":"Nature"},{"key":"8852_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.550","author":"FE Lock","year":"2013","unstructured":"Lock FE, McDonald PC, Lou Y et al (2013) Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Oncogene. https:\/\/doi.org\/10.1038\/onc.2012.550","journal-title":"Oncogene"},{"key":"8852_CR82","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian BZ, Li J, Zhang H et al (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475:222","journal-title":"Nature"},{"key":"8852_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/path.4493","author":"AL Bates","year":"2015","unstructured":"Bates AL, Pickup MW, Hallett MA et al (2015) Stromal matrix metalloproteinase 2 regulates collagen expression and promotes the outgrowth of experimental metastases. J Pathol. https:\/\/doi.org\/10.1002\/path.4493","journal-title":"J Pathol"},{"key":"8852_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.05.017","author":"C Gebhardt","year":"2006","unstructured":"Gebhardt C, N\u00e9meth J, Angel P, Hess J (2006) S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. https:\/\/doi.org\/10.1016\/j.bcp.2006.05.017","journal-title":"Biochem Pharmacol"},{"key":"8852_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.11.005","author":"K Srivastava","year":"2014","unstructured":"Srivastava K, Hu J, Korn C et al (2014) Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccell.2014.11.005","journal-title":"Cancer Cell"},{"key":"8852_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01596-7","author":"H Rezaeeyan","year":"2023","unstructured":"Rezaeeyan H, Gh NM, BF, Arabfard M, (2023) A computational approach for the identification of key genes and biological pathways of chronic lung diseases: a systems biology approach. BMC Med Genomics. https:\/\/doi.org\/10.1186\/s12920-023-01596-7","journal-title":"BMC Med Genomics"},{"key":"8852_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(04)92002-7","author":"L Yang","year":"2004","unstructured":"Yang L, Carbone DP (2004) Tumor-host immune interactions and dendritic cell dysfunction. Adv Cancer Res. https:\/\/doi.org\/10.1016\/S0065-230X(04)92002-7","journal-title":"Adv Cancer Res"},{"key":"8852_CR88","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025702330207","author":"CG Colpaert","year":"2003","unstructured":"Colpaert CG, Vermeulen PB, Fox SB et al (2003) The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis. Breast Cancer Res Treat. https:\/\/doi.org\/10.1023\/A:1025702330207","journal-title":"Breast Cancer Res Treat"},{"key":"8852_CR89","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00262-002-0280-8","volume":"51","author":"S Kusmartsev","year":"2002","unstructured":"Kusmartsev S, Gabrilovich DI (2002) Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother 51:293","journal-title":"Cancer Immunol Immunother"},{"key":"8852_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.10.027","author":"S Ai","year":"2007","unstructured":"Ai S, Cheng XW, Inoue A et al (2007) Angiogenic activity of bFGF and VEGF suppressed by proteolytic cleavage by neutrophil elastase. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2007.10.027","journal-title":"Biochem Biophys Res Commun"},{"key":"8852_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071472","author":"D Zhao","year":"2013","unstructured":"Zhao D, Tu Y, Wan L et al (2013) In vivo monitoring of angiogenesis inhibition via down-regulation of Mir-21 in a VEGFR2-Luc murine breast cancer model using bioluminescent imaging. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0071472","journal-title":"PLoS ONE"},{"key":"8852_CR92","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/CS20110086","volume":"121","author":"JFS Santiba\u00f1ez","year":"2011","unstructured":"Santiba\u00f1ez JFS, Quintanilla M, Bernabeu C (2011) TGF-\u03b2\/TGF-\u03b2 receptor system and its role in physiological and pathological conditions. Clin Sci 121:233","journal-title":"Clin Sci"},{"key":"8852_CR93","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2013.02.048","volume":"341","author":"CD Morrison","year":"2013","unstructured":"Morrison CD, Parvani JG, Schiemann WP (2013) The relevance of the TGF-\u03b2 Paradox to EMT-MET programs. Cancer Lett 341:30\u201340","journal-title":"Cancer Lett"},{"key":"8852_CR94","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2015.05.002","volume":"365","author":"MW Nasser","year":"2015","unstructured":"Nasser MW, Elbaz M, Ahirwar DK, Ganju RK (2015) Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins. Cancer Lett 365:11\u201322","journal-title":"Cancer Lett"},{"key":"8852_CR95","doi-asserted-by":"publisher","DOI":"10.2174\/138161210791034012","author":"AC Hirbe","year":"2010","unstructured":"Hirbe AC, Morgan EA, Weilbaecher KN (2010) The CXCR4\/SDF-1 chemokine axis: a potential therapeutic target for bone metastases? Curr Pharm Des. https:\/\/doi.org\/10.2174\/138161210791034012","journal-title":"Curr Pharm Des"},{"key":"8852_CR96","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","volume":"5","author":"X Guan","year":"2015","unstructured":"Guan X (2015) Cancer metastases: Challenges and opportunities. Acta Pharm Sin B 5:402","journal-title":"Acta Pharm Sin B"},{"key":"8852_CR97","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1949","author":"T Fiaschi","year":"2012","unstructured":"Fiaschi T, Marini A, Giannoni E et al (2012) Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1949","journal-title":"Cancer Res"},{"key":"8852_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28577","author":"AKL Kai","year":"2016","unstructured":"Kai AKL, Chan LK, Lo RCL et al (2016) Down-regulation of TIMP2 by HIF-1\u03b1\/miR-210\/HIF-3\u03b1 regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma. Hepatology. https:\/\/doi.org\/10.1002\/hep.28577","journal-title":"Hepatology"},{"issue":"18","key":"8852_CR99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/S10147-011-0336-X","volume":"181","author":"XF Duan","year":"2011","unstructured":"Duan XF, Dong NN, Zhang T (2011) Li Q (2011) The prognostic analysis of clinical breast cancer subtypes among patients with liver metastases from breast cancer. Int J Clin Oncol 181(18):26\u201332. https:\/\/doi.org\/10.1007\/S10147-011-0336-X","journal-title":"Int J Clin Oncol"},{"key":"8852_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601727","author":"F Stessels","year":"2004","unstructured":"Stessels F, Van Den Eynden G, Van Der Auwera I et al (2004) Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. Br J Cancer. https:\/\/doi.org\/10.1038\/sj.bjc.6601727","journal-title":"Br J Cancer"},{"key":"8852_CR101","doi-asserted-by":"publisher","DOI":"10.1152\/physiologyonline.1999.14.3.117","author":"J Reichen","year":"1999","unstructured":"Reichen J (1999) The role of the sinusoidal endothelium in liver function. News Physiol Sci. https:\/\/doi.org\/10.1152\/physiologyonline.1999.14.3.117","journal-title":"News Physiol Sci"},{"key":"8852_CR102","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2281","author":"SM Rodr\u00edguez-Pinilla","year":"2006","unstructured":"Rodr\u00edguez-Pinilla SM, Sarr\u00edo D, Honrado E et al (2006) Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-2281","journal-title":"Clin Cancer Res"},{"key":"8852_CR103","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/J.ADDR.2011.05.014","volume":"63","author":"JD McAllaster","year":"2011","unstructured":"McAllaster JD, Cohen MS (2011) Role of the lymphatics in cancer metastasis and chemotherapy applications. Adv Drug Deliv Rev 63:867\u2013875. https:\/\/doi.org\/10.1016\/J.ADDR.2011.05.014","journal-title":"Adv Drug Deliv Rev"},{"key":"8852_CR104","first-page":"411","volume":"31","author":"GA Rosenblum","year":"1983","unstructured":"Rosenblum GA (1983) Metastatic breast cancer in the eyelid. Cutis 31:411\u2013417","journal-title":"Cutis"},{"key":"8852_CR105","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3390\/cancers13092053","volume":"13","author":"CM Neophytou","year":"2021","unstructured":"Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P (2021) The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities. Cancers (Basel). 13:2053","journal-title":"Cancers (Basel)."},{"key":"8852_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0202-y","author":"HY Xie","year":"2017","unstructured":"Xie HY, Shao ZM, Li DQ (2017) Tumor microenvironment: Driving forces and potential therapeutic targets for breast cancer metastasis. Chin J Cancer. https:\/\/doi.org\/10.1186\/s40880-017-0202-y","journal-title":"Chin J Cancer"},{"key":"8852_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.08.020","author":"LA Boyer","year":"2005","unstructured":"Boyer LA, Tong IL, Cole MF et al (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. https:\/\/doi.org\/10.1016\/j.cell.2005.08.020","journal-title":"Cell"},{"key":"8852_CR108","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","volume":"129","author":"B Keith","year":"2007","unstructured":"Keith B, Simon MC (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129:465","journal-title":"Cell"},{"key":"8852_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63501-8","author":"T Imai","year":"2003","unstructured":"Imai T, Horiuchi A, Wang C et al (2003) Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol. https:\/\/doi.org\/10.1016\/S0002-9440(10)63501-8","journal-title":"Am J Pathol"},{"key":"8852_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1691","author":"MH Yang","year":"2008","unstructured":"Yang MH, Wu MZ, Chiou SH et al (2008) Direct regulation of TWIST by HIF-1\u03b1 promotes metastasis. Nat Cell Biol. https:\/\/doi.org\/10.1038\/ncb1691","journal-title":"Nat Cell Biol"},{"key":"8852_CR111","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3719","author":"B Krishnamachary","year":"2006","unstructured":"Krishnamachary B, Zagzag D, Nagasawa H et al (2006) Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3719","journal-title":"Cancer Res"},{"key":"8852_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.008","author":"W Guo","year":"2012","unstructured":"Guo W, Keckesova Z, Donaher JL et al (2012) Slug and Sox9 cooperatively determine the mammary stem cell state. Cell. https:\/\/doi.org\/10.1016\/j.cell.2012.02.008","journal-title":"Cell"},{"key":"8852_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.11.012","author":"JT Erler","year":"2009","unstructured":"Erler JT, Bennewith KL, Cox TR et al (2009) Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccr.2008.11.012","journal-title":"Cancer Cell"},{"key":"8852_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/nature04186","author":"RN Kaplan","year":"2005","unstructured":"Kaplan RN, Riba RD, Zacharoulis S et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. https:\/\/doi.org\/10.1038\/nature04186","journal-title":"Nature"},{"key":"8852_CR115","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"EI Deryugina","year":"2006","unstructured":"Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9\u201334","journal-title":"Cancer Metastasis Rev"},{"key":"8852_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.30","author":"I Serrano","year":"2013","unstructured":"Serrano I, Mcdonald PC, Lock FE, Dedhar S (2013) Role of the integrin-linked kinase (ILK)\/Rictor complex in TGF\u03b2-1-induced epithelial-mesenchymal transition (EMT). Oncogene. https:\/\/doi.org\/10.1038\/onc.2012.30","journal-title":"Oncogene"},{"key":"8852_CR117","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E08-05-0506","author":"D Medici","year":"2008","unstructured":"Medici D, Hay ED, Olsen BR (2008) Snail and slug promote epithelial-mesenchymal transition through \u03b2-catenin-T-cell factor-4-dependent expression of transforming growth factor-\u03b23. Mol Biol Cell. https:\/\/doi.org\/10.1091\/mbc.E08-05-0506","journal-title":"Mol Biol Cell"},{"key":"8852_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1112","author":"R Chakrabarti","year":"2012","unstructured":"Chakrabarti R, Wei Y, Romano RA et al (2012) Elf5 regulates mammary gland stem\/progenitor cell fate by influencing notch signaling. Stem Cells. https:\/\/doi.org\/10.1002\/stem.1112","journal-title":"Stem Cells"},{"key":"8852_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2607","author":"R Chakrabarti","year":"2012","unstructured":"Chakrabarti R, Hwang J, Andres Blanco M et al (2012) Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat Cell Biol. https:\/\/doi.org\/10.1038\/ncb2607","journal-title":"Nat Cell Biol"},{"key":"8852_CR120","doi-asserted-by":"publisher","DOI":"10.1126\/science.1228522","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science. https:\/\/doi.org\/10.1126\/science.1228522","journal-title":"Science"},{"key":"8852_CR121","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc3265","volume":"12","author":"T Brabletz","year":"2012","unstructured":"Brabletz T (2012) To differentiate or not-routes towards metastasis. Nat Rev Cancer 12:425","journal-title":"Nat Rev Cancer"},{"key":"8852_CR122","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.2353\/AJPATH.2010.090777","volume":"176","author":"Y Liu","year":"2010","unstructured":"Liu Y, Xiang X, Zhuang X et al (2010) Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am J Pathol 176:2490\u20132499. https:\/\/doi.org\/10.2353\/AJPATH.2010.090777","journal-title":"Am J Pathol"},{"key":"8852_CR123","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1042\/BCJ20170079","volume":"474","author":"O Slaby","year":"2017","unstructured":"Slaby O, Laga R, Sedlacek O (2017) Therapeutic targeting of non-coding RNAs in cancer. Biochem J 474:4219\u20134251. https:\/\/doi.org\/10.1042\/BCJ20170079","journal-title":"Biochem J"},{"key":"8852_CR124","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/J.CELL.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136:642\u2013655. https:\/\/doi.org\/10.1016\/J.CELL.2009.01.035","journal-title":"Cell"},{"key":"8852_CR125","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/J.PHARMTHERA.2016.03.004","volume":"161","author":"MA Parasramka","year":"2016","unstructured":"Parasramka MA, Maji S, Matsuda A et al (2016) Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma. Pharmacol Ther 161:67\u201378. https:\/\/doi.org\/10.1016\/J.PHARMTHERA.2016.03.004","journal-title":"Pharmacol Ther"},{"issue":"37","key":"8852_CR126","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/S13277-015-4572-Y","volume":"372","author":"S Malih","year":"2015","unstructured":"Malih S, Saidijam M (2015) Malih N (2015) A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy. Tumor Biol 372(37):1479\u20131485. https:\/\/doi.org\/10.1007\/S13277-015-4572-Y","journal-title":"Tumor Biol"},{"key":"8852_CR127","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.7150\/IJBS.22531","volume":"13","author":"M Wang","year":"2017","unstructured":"Wang M, Yu F, Wu W et al (2017) Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity. Int J Biol Sci 13:1497\u20131506. https:\/\/doi.org\/10.7150\/IJBS.22531","journal-title":"Int J Biol Sci"},{"key":"8852_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1437-0","author":"Y Wu","year":"2019","unstructured":"Wu Y, Shi W, Tang T et al (2019) miR-29a contributes to breast cancer cells epithelial\u2013mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-019-1437-0","journal-title":"Cell Death Dis"},{"key":"8852_CR129","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.omto.2018.12.011","volume":"12","author":"JJ Kwon","year":"2019","unstructured":"Kwon JJ, Factora TD, Dey S, Kota J (2019) A systematic review of miR-29 in cancer. Mol Ther Oncolytics 12:173","journal-title":"Mol Ther Oncolytics"},{"key":"8852_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.113","author":"MK Nygren","year":"2014","unstructured":"Nygren MK, Tekle C, Ingebrigtsen VA et al (2014) Identifying microRNAs regulating B7\u2013H3 in breast cancer: the clinical impact of microRNA-29c. Br J Cancer. https:\/\/doi.org\/10.1038\/bjc.2014.113","journal-title":"Br J Cancer"},{"key":"8852_CR131","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s43046-022-00120-9","volume":"34","author":"A Raval","year":"2022","unstructured":"Raval A, Joshi J, Shah F (2022) Significance of metastamiR-10b in breast cancer therapeutics. J Egypt Natl Canc Inst 34:19","journal-title":"J Egypt Natl Canc Inst"},{"key":"8852_CR132","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/cdd.2009.58","volume":"17","author":"AH Lund","year":"2010","unstructured":"Lund AH (2010) MiR-10 in development and cancer. Cell Death Differ 17:209\u2013214","journal-title":"Cell Death Differ"},{"key":"8852_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02855-6","author":"C Bao","year":"2020","unstructured":"Bao C, Chen J, Chen D et al (2020) MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-020-02855-6","journal-title":"Cell Death Dis"},{"key":"8852_CR134","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.sabcs-09-6157","author":"S Pan","year":"2009","unstructured":"Pan S, Yu F, Gong C, Song E (2009) Tumor invasion and metastasis initiated by mir-106b in breast cancer by targeting BRMS1 and RB. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.sabcs-09-6157","journal-title":"Cancer Res"},{"key":"8852_CR135","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/cdd.2013.125","volume":"20","author":"E Mogilyansky","year":"2013","unstructured":"Mogilyansky E, Rigoutsos I (2013) The miR-17\/92 cluster: A comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ 20:1603","journal-title":"Cell Death Differ"},{"key":"8852_CR136","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002989","author":"M Zhang","year":"2011","unstructured":"Zhang M, Liu Q, Mi S et al (2011) Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.1002989","journal-title":"J Immunol"},{"key":"8852_CR137","doi-asserted-by":"publisher","DOI":"10.1369\/0022155417702849","author":"I Bar","year":"2017","unstructured":"Bar I, Merhi A, Abdel-Sater F et al (2017) The MicroRNA miR-210 is expressed by cancer cells but also by the tumor microenvironment in triple-negative breast cancer. J Histochem Cytochem. https:\/\/doi.org\/10.1369\/0022155417702849","journal-title":"J Histochem Cytochem"},{"key":"8852_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/nature10661","author":"KJ Png","year":"2012","unstructured":"Png KJ, Halberg N, Yoshida M, Tavazoie SF (2012) A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature. https:\/\/doi.org\/10.1038\/nature10661","journal-title":"Nature"},{"key":"8852_CR139","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/cr.2008.24","volume":"18","author":"S Zhu","year":"2008","unstructured":"Zhu S, Wu H, Wu F et al (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18:350\u2013359. https:\/\/doi.org\/10.1038\/cr.2008.24","journal-title":"Cell Res"},{"key":"8852_CR140","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/cancers11010007","volume":"11","author":"N Wang","year":"2019","unstructured":"Wang N, Tan HY, Feng YG et al (2019) microRNA-23a in human cancer: Its roles, mechanisms and therapeutic relevance. Cancers (Basel). 11:7","journal-title":"Cancers (Basel)."},{"key":"8852_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2401","author":"M Korpal","year":"2011","unstructured":"Korpal M, Ell BJ, Buffa FM et al (2011) Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med. https:\/\/doi.org\/10.1038\/nm.2401","journal-title":"Nat Med"},{"key":"8852_CR142","doi-asserted-by":"publisher","DOI":"10.1177\/1533033819892264","author":"W Yu","year":"2019","unstructured":"Yu W, Li D, Zhang Y et al (2019) MiR-142-5p acts as a significant regulator through promoting proliferation, invasion, and migration in breast cancer modulated by targeting SORBS1. Technol Cancer Res Treat. https:\/\/doi.org\/10.1177\/1533033819892264","journal-title":"Technol Cancer Res Treat"},{"key":"8852_CR143","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/cbin.11530","volume":"45","author":"N Dastmalchi","year":"2021","unstructured":"Dastmalchi N, Baradaran B, Banan Khojasteh SM et al (2021) miR-424: A novel potential therapeutic target and prognostic factor in malignancies. Cell Biol Int 45:720\u2013730","journal-title":"Cell Biol Int"},{"key":"8852_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010012","author":"M Mahajan","year":"2022","unstructured":"Mahajan M, Sitasawad S (2022) Mir-140-5p attenuates hypoxia-induced breast cancer progression by targeting nrf2\/ho-1 axis in a keap1-independent mechanism. Cells. https:\/\/doi.org\/10.3390\/cells11010012","journal-title":"Cells"},{"key":"8852_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107198","author":"M Moradi-Chaleshtori","year":"2021","unstructured":"Moradi-Chaleshtori M, Bandehpour M, Heidari N et al (2021) Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2020.107198","journal-title":"Int Immunopharmacol"},{"key":"8852_CR146","doi-asserted-by":"publisher","first-page":"708765","DOI":"10.3389\/fonc.2021.708765","volume":"11","author":"K Otmani","year":"2021","unstructured":"Otmani K, Lewalle P (2021) Tumor Suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol 11:708765","journal-title":"Front Oncol"},{"key":"8852_CR147","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M804280200","author":"RJ Webster","year":"2009","unstructured":"Webster RJ, Giles KM, Price KJ et al (2009) Regulation of epidermal growth factor receptor signaling in human cancer cells by MicroRNA-7. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M804280200","journal-title":"J Biol Chem"},{"key":"8852_CR148","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201010100","author":"D Xu","year":"2011","unstructured":"Xu D, Takeshita F, Hino Y et al (2011) miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.201010100","journal-title":"J Cell Biol"},{"key":"8852_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.167","author":"F Yu","year":"2010","unstructured":"Yu F, Deng H, Yao H et al (2010) Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene. https:\/\/doi.org\/10.1038\/onc.2010.167","journal-title":"Oncogene"},{"key":"8852_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.03.047","author":"S Valastyan","year":"2009","unstructured":"Valastyan S, Reinhardt F, Benaich N et al (2009) A Pleiotropically Acting MicroRNA, miR-31, inhibits breast cancer metastasis. Cell. https:\/\/doi.org\/10.1016\/j.cell.2009.03.047","journal-title":"Cell"},{"key":"8852_CR151","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707493105","author":"TA Harris","year":"2008","unstructured":"Harris TA, Yamakuchi M, Ferlito M et al (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.0707493105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8852_CR152","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0808042106","author":"M Sachdeva","year":"2009","unstructured":"Sachdeva M, Zhu S, Wu F et al (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.0808042106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8852_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.245","author":"XF Li","year":"2009","unstructured":"Li XF, Yan PJ, Shao ZM (2009) Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene. https:\/\/doi.org\/10.1038\/onc.2009.245","journal-title":"Oncogene"},{"key":"8852_CR154","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2009.18","author":"H Wu","year":"2009","unstructured":"Wu H, Zhu S, Mo YY (2009) Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Res. https:\/\/doi.org\/10.1038\/cr.2009.18","journal-title":"Cell Res"},{"key":"8852_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.181","author":"G Vetter","year":"2010","unstructured":"Vetter G, Saumet A, Moes M et al (2010) MiR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers. Oncogene. https:\/\/doi.org\/10.1038\/onc.2010.181","journal-title":"Oncogene"},{"key":"8852_CR156","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002080107","author":"Z Yu","year":"2010","unstructured":"Yu Z, Willmarth NE, Zhou J et al (2010) microRNA 17\/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.1002080107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8852_CR157","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200801079","author":"Z Yu","year":"2008","unstructured":"Yu Z, Wang C, Wang M et al (2008) A cyclin D1\/microRNA 17\/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.200801079","journal-title":"J Cell Biol"},{"key":"8852_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2010.103","author":"QQ Li","year":"2011","unstructured":"Li QQ, Chen ZQ, Cao XX et al (2011) Involvement of NF-\u03baB\/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ. https:\/\/doi.org\/10.1038\/cdd.2010.103","journal-title":"Cell Death Differ"},{"key":"8852_CR159","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2021","author":"M Sachdeva","year":"2010","unstructured":"Sachdeva M, Mo YY (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2021","journal-title":"Cancer Res"},{"key":"8852_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.11.019","author":"S Ryu","year":"2013","unstructured":"Ryu S, McDonnell K, Choi H et al (2013) Suppression of miRNA-708 by Polycomb Group promotes metastases by calcium-induced cell migration. Cancer Cell. https:\/\/doi.org\/10.1016\/j.ccr.2012.11.019","journal-title":"Cancer Cell"},{"key":"8852_CR161","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883","journal-title":"Cell"},{"key":"8852_CR162","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1101\/gad.314617.118","volume":"32","author":"H Gonzalez","year":"2018","unstructured":"Gonzalez H, Hagerling C, Werb Z (2018) Roles of the immune system in cancer: From tumor initiation to metastatic progression. Genes Dev 32:1267","journal-title":"Genes Dev"},{"key":"8852_CR163","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1038687","author":"X Tian","year":"2015","unstructured":"Tian X, Tian J, Tang X et al (2015) Particulate \u03b2-glucan regulates the immunosuppression of granulocytic myeloid-derived suppressor cells by inhibiting NFIA expression. Oncoimmunology. https:\/\/doi.org\/10.1080\/2162402X.2015.1038687","journal-title":"Oncoimmunology"},{"key":"8852_CR164","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.it.2014.07.005","volume":"35","author":"JA Heward","year":"2014","unstructured":"Heward JA, Lindsay MA (2014) Long non-coding RNAs in the regulation of the immune response. Trends Immunol 35:408","journal-title":"Trends Immunol"},{"key":"8852_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0528-7","author":"J Ji","year":"2018","unstructured":"Ji J, Yin Y, Ju H et al (2018) Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-018-0528-7","journal-title":"Cell Death Dis"},{"key":"8852_CR166","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2017.1317416","author":"K Wu","year":"2017","unstructured":"Wu K, Zhao Z, Liu K et al (2017) Long noncoding RNA lnc-sox5 modulates CRC tumorigenesis by unbalancing tumor microenvironment. Cell Cycle. https:\/\/doi.org\/10.1080\/15384101.2017.1317416","journal-title":"Cell Cycle"},{"key":"8852_CR167","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/RLU.0b013e31819672b9","volume":"34","author":"T. K, H. F, T. N,","year":"2009","unstructured":"T. K, H. F, T. N, et al (2009) Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancer. Clin Nucl Med 34:173","journal-title":"Clin Nucl Med"},{"key":"8852_CR168","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/615923","author":"MA Titi","year":"2010","unstructured":"Titi MA, Anabtawi A, Newland AD (2010) Isolated gastrointestinal metastasis of breast carcinoma: A case report. Case Rep Med. https:\/\/doi.org\/10.1155\/2010\/615923","journal-title":"Case Rep Med"},{"key":"8852_CR169","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317701311","author":"CY Zhang","year":"2017","unstructured":"Zhang CY, Yu MS, Li X et al (2017) Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway. Tumor Biol. https:\/\/doi.org\/10.1177\/1010428317701311","journal-title":"Tumor Biol"},{"key":"8852_CR170","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/J.BIOPHA.2018.05.056","volume":"104","author":"S Li","year":"2018","unstructured":"Li S, Zhou J, Wang Z et al (2018) Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Biomed Pharmacother 104:451\u2013457. https:\/\/doi.org\/10.1016\/J.BIOPHA.2018.05.056","journal-title":"Biomed Pharmacother"},{"key":"8852_CR171","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.12659\/MSM.904892","volume":"23","author":"W Li","year":"2017","unstructured":"Li W, Jia G, Qu Y et al (2017) Long non-coding RNA (LncRNA) HOXA11-AS promotes breast cancer invasion and metastasis by regulating epithelial-mesenchymal transition. Med Sci Monit 23:3393\u20133403","journal-title":"Med Sci Monit"},{"issue":"34","key":"8852_CR172","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1038\/onc.2014.200","volume":"3420","author":"L G\u00f3mez-Maldonado","year":"2015","unstructured":"G\u00f3mez-Maldonado L, Tiana M, Roche O et al (2015) (2014) EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination. Oncogene 3420(34):2609\u20132620. https:\/\/doi.org\/10.1038\/onc.2014.200","journal-title":"Oncogene"},{"issue":"19","key":"8852_CR173","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/ncb3467","volume":"192","author":"W Zhuo","year":"2017","unstructured":"Zhuo W (2017) Kang Y (2017) Lnc-ing ROR1\u2013HER3 and Hippo signalling in metastasis. Nat Cell Biol 192(19):81\u201383. https:\/\/doi.org\/10.1038\/ncb3467","journal-title":"Nat Cell Biol"},{"key":"8852_CR174","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1126\/scisignal.aak9557","volume":"10","author":"W Zhou","year":"2017","unstructured":"Zhou W, Ye XL, Xu J et al (2017) The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b\/c and let-7b. Sci Signal 10:81\u201383","journal-title":"Sci Signal"},{"key":"8852_CR175","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1398-2","author":"S Ren","year":"2019","unstructured":"Ren S, Liu J, Feng Y et al (2019) Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b\/c in breast cancer under hypoxia. J Exp Clin Cancer Res. https:\/\/doi.org\/10.1186\/s13046-019-1398-2","journal-title":"J Exp Clin Cancer Res"},{"key":"8852_CR176","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004942","author":"J Shan","year":"2016","unstructured":"Shan J, Zhang S, Wang Z et al (2016) Breast malignant phyllodes tumor with rare pelvic metastases and long-term overall survival: A case report and literature review. Medicine (United States). https:\/\/doi.org\/10.1097\/MD.0000000000004942","journal-title":"Medicine (United States)"},{"key":"8852_CR177","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-015-0568-x","author":"T Osaku","year":"2015","unstructured":"Osaku T, Ogata H, Magoshi S et al (2015) Metastatic nonpalpable invasive lobular breast carcinoma presenting as rectal stenosis: A case report. J Med Case Rep. https:\/\/doi.org\/10.1186\/s13256-015-0568-x","journal-title":"J Med Case Rep"},{"key":"8852_CR178","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-018-0892-y","author":"T Urade","year":"2019","unstructured":"Urade T, Oka S, Iimori S et al (2019) A resected case of gallbladder metastasis with symptoms of acute cholecystitis in multiple metastatic ductal carcinoma of the breast. Clin J Gastroenterol. https:\/\/doi.org\/10.1007\/s12328-018-0892-y","journal-title":"Clin J Gastroenterol"},{"key":"8852_CR179","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2018-520","author":"B Chen","year":"2018","unstructured":"Chen B, Huang X, Wei W et al (2018) Abstract 520: circEPSTI1 as a prognostic marker and mediator of triple-negative breast cancer progression. Cancer Res. https:\/\/doi.org\/10.1158\/1538-7445.am2018-520","journal-title":"Cancer Res"},{"key":"8852_CR180","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0946-x","author":"H Tang","year":"2019","unstructured":"Tang H, Huang X, Wang J et al (2019) CircKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-019-0946-x","journal-title":"Mol Cancer"},{"key":"8852_CR181","doi-asserted-by":"publisher","first-page":"95704","DOI":"10.18632\/oncotarget.21183","volume":"8","author":"N Yan","year":"2017","unstructured":"Yan N, Xu H, Zhang J et al (2017) Circular RNA profile indicates circular RNA VRK1 is negatively related with breast cancer stem cells. Oncotarget 8:95704\u201395718","journal-title":"Oncotarget"},{"key":"8852_CR182","doi-asserted-by":"publisher","first-page":"S415","DOI":"10.1016\/J.PMRJ.2017.08.403","volume":"9","author":"S Maltser","year":"2017","unstructured":"Maltser S, Cristian A, Silver JK et al (2017) A focused review of safety considerations in cancer rehabilitation. PM R 9:S415. https:\/\/doi.org\/10.1016\/J.PMRJ.2017.08.403","journal-title":"PM R"},{"key":"8852_CR183","unstructured":"Complications of Advanced (Metastatic) Breast Cancer. https:\/\/www.verywellhealth.com\/complications-of-advanced-metastatic-breast-cancer-4159828. Accessed 30 Mar 2022"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08852-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08852-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08852-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T13:06:19Z","timestamp":1699535179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08852-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":183,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["8852"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08852-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"23 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}